Summary
| Direction in Long COVID | ↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction |
|---|---|
| Category | Metabolic |
| Also described as | Fatty acid transport |
| Compared against | HC, R (healthy controls, recovered individuals without persistent symptoms) |
| Associated symptoms | Mitochondrial fatty acid oxidation |
| Test type | Blood test (serum / plasma / whole blood) |
| Source | Baalbaki et al. 2025 — doi:10.1111/all.16526 |
| Condition atlas | Long COVID Biomarker Atlas |
Trials, interventions and tests
Also sold as a nutrient or supplement
L-Carnitine / Acylcarnitines (supplement). Includes ALCAR and acylcarnitine complexes. This tag means the analyte is also available orally; it is not a product endorsement and a low or high level does not by itself justify supplementation.
Related Metabolic markers in Long COVID
- Lactate ↑
- 4-Aminobutanoate (GABA) ↑
- Xanthine ↑
- Thymine ↓
- Uracil ↓
- Porphobilinogen ↑
- 5-Aminolevulinate ↑
- Putrescine ↑
Full list: Long COVID Biomarker Atlas.
Frequently asked questions
Is Carnitine / Acylcarnitines high or low in Long COVID?
Mixed. Some studies report higher and others lower Carnitine / Acylcarnitines in Long COVID compared with healthy controls, recovered individuals without persistent symptoms, so no single direction is established. Source: Baalbaki et al. 2025.
What symptoms is Carnitine / Acylcarnitines associated with in Long COVID?
The cited literature associates this marker with Mitochondrial fatty acid oxidation. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures Carnitine / Acylcarnitines?
It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal Carnitine / Acylcarnitines result diagnostic of Long COVID?
No. No single biomarker is diagnostic of Long COVID. Carnitine / Acylcarnitines findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.